Assessing Psoriatic Arthritis Research For the Future

Video

Philip Mease shared that he and his team are in the midst of preparing the content of the studies for publication to ensure continued education of psoriatic arthritis treatment.

Philip Mease shared that he and his team are in the midst of preparing the content of the studies for publication to ensure continued education about psoriatic arthritis treatment. Mease concluded, "We're very excited about this new data because this a patient population that historically has had few treatments at least until the anti-TNF medicines came along, and now we're finding that for patients who don't respond adequately to the anti-TNFs, it's important to have new mechanisms of action for treating this very important population of rheumatology patients."

Recent Videos
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
© 2024 MJH Life Sciences

All rights reserved.